NORDIC MEDICAL SOLUTIONS ApS: Financial statements 2016
CVR: 34352542
Source: annual report 2016, Danish Business Authority
01/07/2015 – 30/06/2016
NORDIC MEDICAL SOLUTIONS ApS (CVR 34352542) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 23,136,236 and a net result of DKK 15,251,087 compared with DKK 11,259,050 the year before. That is an increase of 30.7% compared with the year before. Equity in the 2016 report amounted to DKK 16,831,087. The solvency ratio was 57.2%.
- Gross Profit
- DKK 23,136,236
- Profit/Loss
- DKK 15,251,087
- Equity
- DKK 16,831,087
- Total Assets
- DKK 29,428,437
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 23.1M | 15.3M | 16.8M | - |
| 2015 | - | 17.7M | 11.3M | 12M | - |
| 2014 | - | 8M | 3.3M | 2.5M | - |
| 2013 | - | 5.5M | 1M | 1.5M | - |
Official annual report
Find more companies like NORDIC MEDICAL SOLUTIONS ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2016
As of October 1, 2016, Carsten Gunnar Olesen has joined the board of directors of NORDIC MEDICAL SOLUTIONS ApS.
As of April 21, 2016, A/S PSE 17 NR. 1056 has been appointed auditor of NORDIC MEDICAL SOLUTIONS ApS.
As of April 21, 2016, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of NORDIC MEDICAL SOLUTIONS ApS.
About NORDIC MEDICAL SOLUTIONS ApS
NORDIC MEDICAL SOLUTIONS ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2012. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named NORDIC PHARMA SOLUTIONS ApS. The management consists of Pernille Wandrup Rex. The board consists of Kim Erik Ginnerup (chair), Monica Reib, Pernille Wandrup Rex and Philip Fischer Stavnstrup. The company is owned by NMS Group A/S. The company has 16 employees (2026). In 2026, the company reported a gross profit of DKK 56,510,150 and a net result of DKK 31,681,814 compared with DKK 28,614,955 the year before. Equity in the 2026 report amounted to DKK 40,681,814.
